• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Progression of aortic pulse wave velocity in patients with chronic kidney disease.慢性肾病患者主动脉脉搏波速度的进展
J Clin Hypertens (Greenwich). 2013 Nov;15(11):833-8. doi: 10.1111/jch.12198. Epub 2013 Sep 16.
2
Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2-4.主动脉脉搏波速度可预测2-4期慢性肾脏病患者的死亡率。
J Hypertens. 2014 Apr;32(4):899-903. doi: 10.1097/HJH.0000000000000113.
3
Aortic pulse wave velocity, central pulse pressure, augmentation index and chronic kidney disease progression in individuals with type 2 diabetes: a 3- year prospective study.2 型糖尿病患者的主动脉脉搏波速度、中心脉压、增强指数与慢性肾脏病进展:一项为期 3 年的前瞻性研究。
BMC Nephrol. 2020 Aug 20;21(1):359. doi: 10.1186/s12882-020-02024-z.
4
Lower-extremity arterial stiffness vs. aortic stiffness in the general population.一般人群中下肢动脉僵硬度与主动脉僵硬度的比较。
Hypertens Res. 2013 Aug;36(8):718-24. doi: 10.1038/hr.2013.21. Epub 2013 Apr 11.
5
Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study.主动脉脉搏波速度作为慢性阻塞性肺疾病心血管风险的衡量指标:来自 ARCADE 研究的两年随访数据。
Medicina (Kaunas). 2019 Apr 2;55(4):89. doi: 10.3390/medicina55040089.
6
Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.在晚期慢性肾脏病中,动脉僵硬度的进展与骨矿物质标志物的变化有关。
BMC Nephrol. 2017 Sep 4;18(1):281. doi: 10.1186/s12882-017-0705-4.
7
Is fatty acid intake a predictor of arterial stiffness and blood pressure in men? Evidence from the Caerphilly Prospective Study.脂肪酸摄入量是否可预测男性的动脉僵硬度和血压?来自卡菲利前瞻性研究的证据。
Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1079-85. doi: 10.1016/j.numecd.2012.12.002. Epub 2013 Feb 13.
8
Association of renal resistive index with aortic pulse wave velocity in hypertensive patients.高血压患者肾阻力指数与主动脉脉搏波速度的相关性
Eur J Prev Cardiol. 2015 Apr;22(4):415-22. doi: 10.1177/2047487314524683. Epub 2014 Feb 11.
9
Subclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction.心血管疾病的亚临床标志物可预测左心室射血分数正常的慢性肾脏病患者的不良结局。
Int J Cardiovasc Imaging. 2017 May;33(5):687-698. doi: 10.1007/s10554-016-1059-x. Epub 2017 Jan 24.
10
Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years.动脉僵硬度增加是 60 岁以下 2 型糖尿病患者肾功能下降的独立预测因子。
J Am Heart Assoc. 2017 Mar 30;6(4):e004934. doi: 10.1161/JAHA.116.004934.

引用本文的文献

1
Relationship between pulse wave velocity progression and baseline heart rate and its change over 3.7 years of follow-up in hypertensive patients.高血压患者脉搏波速度进展与基线心率之间的关系及其在3.7年随访中的变化
J Hypertens. 2025 Oct 1;43(10):1686-1694. doi: 10.1097/HJH.0000000000004106. Epub 2025 Jul 24.
2
Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients.通过脉搏波速度和超微血管成像对透析前患者血管损伤进行无创评估。
Biomedicines. 2025 Mar 4;13(3):621. doi: 10.3390/biomedicines13030621.
3
Changes in the cardiovascular risk profile in children approaching kidney replacement therapy.接近肾脏替代治疗的儿童心血管风险状况的变化。
EClinicalMedicine. 2024 Jul 3;74:102708. doi: 10.1016/j.eclinm.2024.102708. eCollection 2024 Aug.
4
Assessing the strengths and limitations of non-invasive blood pressure measurement.评估无创血压测量的优势与局限性。
J Clin Hypertens (Greenwich). 2023 Oct;25(10):965-966. doi: 10.1111/jch.14731. Epub 2023 Sep 19.
5
Exercise modulates sympathetic and vascular function in chronic kidney disease.运动调节慢性肾脏病的交感神经和血管功能。
JCI Insight. 2023 Feb 22;8(4):e164221. doi: 10.1172/jci.insight.164221.
6
Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.通过调节镁和磷酸盐逆转动脉疾病(ROADMAP 研究):一项评估柠檬酸镁补充和磷酸盐结合疗法对中度慢性肾脏病患者动脉僵硬影响的随机对照试验的原理和设计。
Trials. 2022 Sep 12;23(1):769. doi: 10.1186/s13063-022-06562-9.
7
Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review.慢性肾脏病与脉搏波速度:一篇叙述性综述
Int J Hypertens. 2019 Feb 17;2019:9189362. doi: 10.1155/2019/9189362. eCollection 2019.
8
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study.我们能否通过降低 CKD 中的磷酸盐来改善心血管结局?降低磷酸盐对慢性肾脏病血管终点影响的研究(IMPROVE-CKD)的原理和方案。
BMJ Open. 2019 Feb 21;9(2):e024382. doi: 10.1136/bmjopen-2018-024382.
9
Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.在晚期慢性肾脏病中,动脉僵硬度的进展与骨矿物质标志物的变化有关。
BMC Nephrol. 2017 Sep 4;18(1):281. doi: 10.1186/s12882-017-0705-4.
10
Clinical Considerations for the Association between Vascular Damage and Chronic Kidney Disease.血管损伤与慢性肾脏病关联的临床考量
Pulse (Basel). 2014 May;2(1-4):81-94. doi: 10.1159/000374092. Epub 2015 Feb 27.

本文引用的文献

1
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.动脉僵硬度预测心血管事件和全因死亡率:系统评价和荟萃分析。
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27. doi: 10.1016/j.jacc.2009.10.061.
2
Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4.主动脉僵硬度与慢性肾脏病 3 期和 4 期的肾功能下降速度独立相关。
Hypertension. 2010 May;55(5):1110-5. doi: 10.1161/HYPERTENSIONAHA.109.143024. Epub 2010 Mar 8.
3
Aortic PWV in chronic kidney disease: a CRIC ancillary study.慢性肾脏病患者的主动脉脉搏波速度:CRIC 辅助研究。
Am J Hypertens. 2010 Mar;23(3):282-9. doi: 10.1038/ajh.2009.240. Epub 2009 Dec 17.
4
Pulse wave velocity and vascular calcification at different stages of chronic kidney disease.脉搏波速度与慢性肾脏病不同阶段的血管钙化。
J Hypertens. 2010 Jan;28(1):163-9. doi: 10.1097/HJH.0b013e328331b81e.
5
Assessment and significance of arterial stiffness in patients with chronic kidney disease.慢性肾脏病患者动脉僵硬度的评估及其意义
Curr Opin Nephrol Hypertens. 2008 Nov;17(6):635-41. doi: 10.1097/mnh.0b013e32830dcd5c.
6
Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD.胰岛素抵抗、炎症和血压决定了慢性肾脏病中的血管功能障碍。
Am J Kidney Dis. 2006 Dec;48(6):926-34. doi: 10.1053/j.ajkd.2006.08.008.
7
Expert consensus document on arterial stiffness: methodological issues and clinical applications.动脉僵硬度专家共识文件:方法学问题与临床应用
Eur Heart J. 2006 Nov;27(21):2588-605. doi: 10.1093/eurheartj/ehl254. Epub 2006 Sep 25.
8
Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.2型糖尿病合并慢性肾脏病患者的局部动脉僵硬度
J Am Soc Nephrol. 2006 Aug;17(8):2245-52. doi: 10.1681/ASN.2005101038. Epub 2006 Jul 12.
9
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population.主动脉脉搏波速度作为一般人群动脉僵硬度指标的预后价值。
Circulation. 2006 Feb 7;113(5):664-70. doi: 10.1161/CIRCULATIONAHA.105.579342.
10
Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease.轻度至中度慢性肾脏病中的动脉僵硬度与动脉扩张
Kidney Int. 2006 Jan;69(2):350-7. doi: 10.1038/sj.ki.5000047.

慢性肾病患者主动脉脉搏波速度的进展

Progression of aortic pulse wave velocity in patients with chronic kidney disease.

作者信息

Tholen Susanne, Klofat Katharina, Pan Cheng Rui, Schmaderer Christoph, Lutz Jens, Heemann Uwe, Baumann Marcus

机构信息

Department of Nephrology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.

出版信息

J Clin Hypertens (Greenwich). 2013 Nov;15(11):833-8. doi: 10.1111/jch.12198. Epub 2013 Sep 16.

DOI:10.1111/jch.12198
PMID:24102750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033812/
Abstract

Aortic pulse wave velocity (aPWV) is elevated in patients with chronic kidney disease (CKD) and predicts cardiovascular risk. However, the natural progression of arterial stiffness in these patients remains uncertain. Therefore, the main aim of this study was to investigate the development of aPWV and to identify potential factors associated with its progression. aPWV measurement was carried out in 70 CKD patients at baseline and after 12 months. Correlations to several variables, in particular annual glomerular filtration rate reduction and diabetes mellitus, were studied. In the cohort, aPWV significantly increased in 1 year by 1.1 m/s (P<.01). Dividing the group into patients with stable and progressive aPWV, factors associated with accelerated progression were age, systolic blood pressure, and diabetes, whereas loss of renal function had no significant impact. The annual aPWV progression in CKD patients reached 1 m/s, which predicts an increased cardiovascular risk. Variables involved with progressive arterial stiffness need further evaluation.

摘要

慢性肾脏病(CKD)患者的主动脉脉搏波速度(aPWV)升高,且可预测心血管风险。然而,这些患者动脉僵硬度的自然进展仍不确定。因此,本研究的主要目的是调查aPWV的发展情况,并确定与其进展相关的潜在因素。对70例CKD患者在基线时和12个月后进行了aPWV测量。研究了其与几个变量的相关性,特别是每年肾小球滤过率降低和糖尿病。在该队列中,aPWV在1年内显著增加了1.1 m/s(P<0.01)。将该组患者分为aPWV稳定和进展的患者,与加速进展相关的因素为年龄、收缩压和糖尿病,而肾功能丧失无显著影响。CKD患者的年aPWV进展达到1 m/s,这预示着心血管风险增加。与动脉僵硬度进展相关的变量需要进一步评估。